PPARγ and Apoptosis in Cancer
2008
PPARγ and Apoptosis in Cancer
publication
10 minutes
Evidence: moderate
Author Information
Author(s): H. A. Elrod, Shi-Yong Sun
Primary Institution: Winship Cancer Institute, Emory University School of Medicine
Hypothesis
PPARγ ligands can induce apoptosis of cancer cells with antitumor activity.
Conclusion
PPARγ ligands have potential in cancer therapy and chemoprevention by inducing apoptosis in cancer cells.
Supporting Evidence
- PPARγ ligands can induce apoptosis in various cancer cells including thyroid, colon, and lung cancer.
- Different mechanisms of apoptosis induction by PPARγ ligands have been identified, both dependent and independent of PPARγ.
- Combination therapies using PPARγ ligands with other anticancer agents enhance apoptosis in cancer cells.
Takeaway
This study talks about how certain substances can help kill cancer cells by making them die in a controlled way, which is important for treating cancer.
Methodology
The review discusses various studies on the role of PPARγ and its ligands in inducing apoptosis in different cancer types.
Limitations
The review does not provide new experimental data but summarizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website